EP Patent

EP0334119A1 — Compounds for inhibiting the biosynthesis of lipoxygenase-derived metabolites of arachidonic acid

Assigned to Boehringer Ingelheim Pharmaceuticals Inc · Expires 1989-09-27 · 37y expired

What this patent protects

Compounds having the formula inhibit 5-lypoxyogenase and are useful in the treatment of inflammation.

USPTO Abstract

Compounds having the formula inhibit 5-lypoxyogenase and are useful in the treatment of inflammation.

Drugs covered by this patent

Patent Metadata

Patent number
EP0334119A1
Jurisdiction
EP
Classification
—
Expires
1989-09-27
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.